Conference Coverage

VIDEO: Isotretinoin revisited: the good, the bad, the latest


 

AT THE CARIBBEAN DERMATOLOGY SYMPOSIUM

GRAND CAYMAN – More than 30 years after isotretinoin became available for the treatment of acne, what are some of the tropes that still hold true? And what misperceptions persist? In a video interview, Dr. Julie C. Harper, a private practitioner in Birmingham, Ala., shares the most up-to-date evidence for and against the drug’s use in patients with acne, including a look at the risk for depression and inflammatory bowel disease, among other tips for prescribing this drug in practice. She was interviewed at the Caribbean Dermatology Symposium provided by Global Academy for Medical Education.

Global Academy and this news organization are owned by the same parent company.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

EADV: Pediatric psoriasis called ‘grossly undertreated’
MDedge Pediatrics
EADV: New long-term data on biologics for pediatric psoriasis ‘encouraging’
MDedge Pediatrics
EADV: Fresh insights into Gorlin syndrome
MDedge Pediatrics
FDA proposes ban on indoor tanning for minors
MDedge Pediatrics
Botanical over-the-counter regimen reduces acne lesions
MDedge Pediatrics
Antibiotic course durations for uncomplicated SSTIs reduced by hospital initiative
MDedge Pediatrics
VIDEO: Treating your atopic dermatitis patients more effectively
MDedge Pediatrics
Studies backed propranolol in treating infantile hemangioma
MDedge Pediatrics
VIDEO: Prophylaxis for atopic dermatitis
MDedge Pediatrics
VIDEO: N-acetylcysteine for ichthyosis, OCD behaviors
MDedge Pediatrics